78 related articles for article (PubMed ID: 7624936)
1. HLA-B44-restricted minor antigen.
Tiercy JM; Jeannet M; Roosnek E
Transplantation; 1995 Jul; 60(1):113-4. PubMed ID: 7624936
[No Abstract] [Full Text] [Related]
2. HLA-B44 subtyping in the Catalan population using reference strand mediated conformation analysis. Implications for the selection of unrelated bone marrow donors.
Gallardo D; Aróstegui JI; Rodríguez-Luaces M; Querol S; González JR; García-López J; Grañena A
Tissue Antigens; 2000 Aug; 56(2):173-7. PubMed ID: 11019921
[TBL] [Abstract][Full Text] [Related]
3. HLA-A and -B alleles in cornea donors as risk factors for graft rejection.
Creemers PC; Kahn D; Hill JC
Transpl Immunol; 1999 Mar; 7(1):15-8. PubMed ID: 10375073
[TBL] [Abstract][Full Text] [Related]
4. A human minor histocompatibility antigen which appears to segregate with the major histocompatibility complex.
Vinci G; Masset M; Semana G; Vernant JP
Transplantation; 1994 Aug; 58(3):361-7. PubMed ID: 8053061
[TBL] [Abstract][Full Text] [Related]
5. A single minor histocompatibility antigen encoded by UGT2B17 and presented by human leukocyte antigen-A*2902 and -B*4403.
Terakura S; Murata M; Warren EH; Sette A; Sidney J; Naoe T; Riddell SR
Transplantation; 2007 May; 83(9):1242-8. PubMed ID: 17496542
[TBL] [Abstract][Full Text] [Related]
6. Molecular analysis of a novel HLA-A33 subtype associated with HLA-B44.
Kato N; Kikuchi A; Kano K; Egawa K; Takiguchi M
Tissue Antigens; 1993 Apr; 41(4):211-3. PubMed ID: 8362415
[No Abstract] [Full Text] [Related]
7. Multiple minor histocompatibility antigen-specific cytotoxic T lymphocyte clones can be generated during graft rejection after HLA-identical bone marrow transplantation.
Marijt WA; Kernan NA; Diaz-Barrientos T; Veenhof WF; O'Reilly RJ; Willemze R; Falkenburg JH
Bone Marrow Transplant; 1995 Jul; 16(1):125-32. PubMed ID: 7581111
[TBL] [Abstract][Full Text] [Related]
8. HLA-B44-directed cytotoxic T cells associated with acute graft-versus-host disease following unrelated bone marrow transplantation.
Keever CA; Leong N; Cunningham I; Copelan EA; Avalos BR; Klein J; Kapoor N; Adams PW; Orosz CG; Tutschka PJ
Bone Marrow Transplant; 1994 Jul; 14(1):137-45. PubMed ID: 7951101
[TBL] [Abstract][Full Text] [Related]
9. A novel HLA-B*44 allele, HLA-B*4459, identified in a renal patient with aberrant B44 serology and characterized by sequence-based typing.
Hammond L; Dunn PP
Tissue Antigens; 2008 Nov; 72(5):494-5. PubMed ID: 18764811
[TBL] [Abstract][Full Text] [Related]
10. The MHC influences acute graft versus host disease in MHC matched adults undergoing allogeneic bone marrow transplantation.
Smyth LA; Witt CS; Christiansen FT; Herrmann RP; Hollingsworth PN; Townend DC; Edward E; Dawkins RL
Bone Marrow Transplant; 1993 Oct; 12(4):351-5. PubMed ID: 8275034
[TBL] [Abstract][Full Text] [Related]
11. Do maternal HLA antigens predispose to schizophrenia?
Wright P; Murray RM; Donaldson PT; Underhill JA
Lancet; 1993 Jul; 342(8863):117-8. PubMed ID: 8100884
[No Abstract] [Full Text] [Related]
12. Bone marrow transplantation. Making just the right match.
Parham P
Nature; 1991 Mar; 350(6314):111-3. PubMed ID: 2005958
[No Abstract] [Full Text] [Related]
13. Human leucocyte antigens and tardive dyskinesia.
Brown KW; White T
Br J Psychiatry; 1991 Feb; 158():270-2. PubMed ID: 1672828
[TBL] [Abstract][Full Text] [Related]
14. Use of solid phase automated sequencing to define HLA disparity between bone marrow donors and recipients.
Baxter-Lowe LA; Keever C; Dinauer D; Daniels T; Johnson K; Camitta B; Drobyski W; Garbrecht F; Horowitz M; Pietryga D
Transplant Proc; 1995 Feb; 27(1):1377-8. PubMed ID: 7878917
[No Abstract] [Full Text] [Related]
15. Sex ratios and hormones in HLA related rheumatic diseases.
James WH
Ann Rheum Dis; 1991 Jun; 50(6):401-4. PubMed ID: 2059084
[TBL] [Abstract][Full Text] [Related]
16. A human minor histocompatibility antigen specific for B cell acute lymphoblastic leukemia.
Dolstra H; Fredrix H; Maas F; Coulie PG; Brasseur F; Mensink E; Adema GJ; de Witte TM; Figdor CG; van de Wiel-van Kemenade E
J Exp Med; 1999 Jan; 189(2):301-8. PubMed ID: 9892612
[TBL] [Abstract][Full Text] [Related]
17. Antagonism of antiviral and allogeneic activity of a human public CTL clonotype by a single altered peptide ligand: implications for allograft rejection.
Ely LK; Green KJ; Beddoe T; Clements CS; Miles JJ; Bottomley SP; Zernich D; Kjer-Nielsen L; Purcell AW; McCluskey J; Rossjohn J; Burrows SR
J Immunol; 2005 May; 174(9):5593-601. PubMed ID: 15843558
[TBL] [Abstract][Full Text] [Related]
18. Human heart endothelial-cell-restricted allorecognition.
Jutte NH; Knoop CJ; Heijse P; Balk AH; Mochtar B; Claas FH; Weimar W
Transplantation; 1996 Aug; 62(3):403-6. PubMed ID: 8779690
[TBL] [Abstract][Full Text] [Related]
19. Bone marrow-allograft rejection by T lymphocytes recognizing a single amino acid difference in HLA-B44.
Fleischhauer K; Kernan NA; O'Reilly RJ; Dupont B; Yang SY
N Engl J Med; 1990 Dec; 323(26):1818-22. PubMed ID: 2247120
[No Abstract] [Full Text] [Related]
20. Tolerance to an HLA-B,DR disparate kidney allograft after bone-marrow transplantation from same donor.
Jacobsen N; Taaning E; Ladefoged J; Kristensen JK; Pedersen FK
Lancet; 1994 Mar; 343(8900):800. PubMed ID: 7907762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
